世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

NGSベースのRNA-seqの世界市場 2023-2027


Global NGS-based RNA-seq Market 2023-2027

NGSベースのRNA-seqの世界市場 2023-2027 TechnavioはNGSベースのRNA-seq市場を監視しており、2023年から2027年の間に37億5373万ドルの成長が見込まれ、予測期間中にCAGR15.34%で加速しています。当レポートでは... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年11月22日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

NGSベースのRNA-seqの世界市場 2023-2027
TechnavioはNGSベースのRNA-seq市場を監視しており、2023年から2027年の間に37億5373万ドルの成長が見込まれ、予測期間中にCAGR15.34%で加速しています。当レポートでは、NGSベースRNA-seq市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向と推進要因、市場全体の環境に関する最新の分析を提供しています。市場は、次世代シーケンシング手法の採用の増加、シーケンシングプラットフォームの技術的進歩、幅広い次世代シーケンシング製品の入手が可能であることが要因となっています。
TechnavioのNGSベースのRNA-seq市場は、以下のように区分されています。
エンドユーザー別
- 学術・研究機関
- 臨床研究
- 製薬会社
- 病院
技術別
- 合成によるシーケンシング
- イオン半導体シーケンサー
- 1分子リアルタイムシークエンシング
- その他
地域別状況
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、次世代シーケンス技術の進歩が、今後数年間のNGSベースRNA-seq市場の成長を促進する主要な理由の1つであると特定しています。また、遺伝子配列決定のコスト削減、バイオインフォマティクスとクラウドベースのソフトウェアプログラムの分野での発展が、市場での大きな需要につながると考えられます。
Technavioは、複数のソースからのデータの調査、合成、主要パラメータの分析による総括という方法で、市場の詳細な姿を提示します。NGSベースのRNA-seq市場に関する当レポートの対象領域は以下の通りです。
- NGSベースのRNA-seq市場のサイジング
- NGSベースRNA-seqの市場予測
- NGSベースのRNA-seq市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Agilent Technologies Inc.、BGI Genomics Co.Ltd.、Brooks Automation Inc.、DNASTAR Inc.、Eurofins Scientific SE、F. Hoffmann La Roche Ltd.、Hamilton Bonaduz AG、Illumina Inc、Precigen Inc、Pacific Biosciences of California Inc、PerkinElmer Inc、PierianDx Inc、Psomagen Inc、 QIAGEN NV、Takara Bio Inc、 Tecan Trading AG、 Thermo Fisher Scientific Inc、および Zymo Research Corp.などの主要ベンダーについて詳しく分析しています。また、NGSベースのRNA-seq市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/ngs-based-rna-seq-market-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global NGS-based RNA-seq market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
o 4.2 End User Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
o 4.3 Technology Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Acamedic and research centers - Market size and forecast 2022-2027
o Exhibit 34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
o 6.4 Clinical research - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
o 6.5 Pharma companies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
o 6.6 Hospitals - Market size and forecast 2022-2027
o Exhibit 46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by End-user
o Exhibit 50: Market opportunity by End-user ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 51: Chart on Technology - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Technology - Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 53: Chart on Comparison by Technology
o Exhibit 54: Data Table on Comparison by Technology
o 7.3 Sequencing by synthesis - Market size and forecast 2022-2027
o Exhibit 55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
o 7.4 Ion semiconductor sequencing - Market size and forecast 2022-2027
o Exhibit 59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
o 7.5 Single-molecule real-time sequencing - Market size and forecast 2022-2027
o Exhibit 63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Technology
o Exhibit 71: Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Singapore - Market size and forecast 2022-2027
o Exhibit 105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 120: Agilent Technologies Inc. - Overview
o Exhibit 121: Agilent Technologies Inc. - Business segments
o Exhibit 122: Agilent Technologies Inc. - Key news
o Exhibit 123: Agilent Technologies Inc. - Key offerings
o Exhibit 124: Agilent Technologies Inc. - Segment focus
o 12.4 BGI Genomics Co. Ltd.
o Exhibit 125: BGI Genomics Co. Ltd. - Overview
o Exhibit 126: BGI Genomics Co. Ltd. - Product / Service
o Exhibit 127: BGI Genomics Co. Ltd. - Key offerings
o 12.5 Brooks Automation Inc.
o Exhibit 128: Brooks Automation Inc. - Overview
o Exhibit 129: Brooks Automation Inc. - Business segments
o Exhibit 130: Brooks Automation Inc. - Key offerings
o Exhibit 131: Brooks Automation Inc. - Segment focus
o 12.6 Eurofins Scientific SE
o Exhibit 132: Eurofins Scientific SE - Overview
o Exhibit 133: Eurofins Scientific SE - Business segments
o Exhibit 134: Eurofins Scientific SE - Key news
o Exhibit 135: Eurofins Scientific SE - Key offerings
o Exhibit 136: Eurofins Scientific SE - Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 Hamilton Bonaduz AG
o Exhibit 142: Hamilton Bonaduz AG - Overview
o Exhibit 143: Hamilton Bonaduz AG - Product / Service
o Exhibit 144: Hamilton Bonaduz AG - Key offerings
o 12.9 Illumina Inc.
o Exhibit 145: Illumina Inc. - Overview
o Exhibit 146: Illumina Inc. - Business segments
o Exhibit 147: Illumina Inc. - Key news
o Exhibit 148: Illumina Inc. - Key offerings
o Exhibit 149: Illumina Inc. - Segment focus
o 12.10 Pacific Biosciences of California Inc.
o Exhibit 150: Pacific Biosciences of California Inc. - Overview
o Exhibit 151: Pacific Biosciences of California Inc. - Product / Service
o Exhibit 152: Pacific Biosciences of California Inc. - Key offerings
o 12.11 PerkinElmer Inc.
o Exhibit 153: PerkinElmer Inc. - Overview
o Exhibit 154: PerkinElmer Inc. - Business segments
o Exhibit 155: PerkinElmer Inc. - Key news
o Exhibit 156: PerkinElmer Inc. - Key offerings
o Exhibit 157: PerkinElmer Inc. - Segment focus
o 12.12 Psomagen Inc.
o Exhibit 158: Psomagen Inc. - Overview
o Exhibit 159: Psomagen Inc. - Product / Service
o Exhibit 160: Psomagen Inc. - Key offerings
o 12.13 QIAGEN NV
o Exhibit 161: QIAGEN NV - Overview
o Exhibit 162: QIAGEN NV - Product / Service
o Exhibit 163: QIAGEN NV - Key news
o Exhibit 164: QIAGEN NV - Key offerings
o 12.14 Takara Bio Inc.
o Exhibit 165: Takara Bio Inc. - Overview
o Exhibit 166: Takara Bio Inc. - Product / Service
o Exhibit 167: Takara Bio Inc. - Key offerings
o 12.15 Tecan Trading AG
o Exhibit 168: Tecan Trading AG - Overview
o Exhibit 169: Tecan Trading AG - Business segments
o Exhibit 170: Tecan Trading AG - Key offerings
o Exhibit 171: Tecan Trading AG - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 172: Thermo Fisher Scientific Inc. - Overview
o Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 174: Thermo Fisher Scientific Inc. - Key news
o Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Zymo Research Corp.
o Exhibit 177: Zymo Research Corp. - Overview
o Exhibit 178: Zymo Research Corp. - Product / Service
o Exhibit 179: Zymo Research Corp. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 180: Inclusions checklist
o Exhibit 181: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 182: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 183: Research methodology
o Exhibit 184: Validation techniques employed for market sizing
o Exhibit 185: Information sources
o 13.5 List of abbreviations
o Exhibit 186: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by End-user ($ million)
Exhibits51: Chart on Technology - Market share 2022-2027 (%)
Exhibits52: Data Table on Technology - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Technology
Exhibits54: Data Table on Comparison by Technology
Exhibits55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Technology ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Agilent Technologies Inc. - Overview
Exhibits121: Agilent Technologies Inc. - Business segments
Exhibits122: Agilent Technologies Inc. - Key news
Exhibits123: Agilent Technologies Inc. - Key offerings
Exhibits124: Agilent Technologies Inc. - Segment focus
Exhibits125: BGI Genomics Co. Ltd. - Overview
Exhibits126: BGI Genomics Co. Ltd. - Product / Service
Exhibits127: BGI Genomics Co. Ltd. - Key offerings
Exhibits128: Brooks Automation Inc. - Overview
Exhibits129: Brooks Automation Inc. - Business segments
Exhibits130: Brooks Automation Inc. - Key offerings
Exhibits131: Brooks Automation Inc. - Segment focus
Exhibits132: Eurofins Scientific SE - Overview
Exhibits133: Eurofins Scientific SE - Business segments
Exhibits134: Eurofins Scientific SE - Key news
Exhibits135: Eurofins Scientific SE - Key offerings
Exhibits136: Eurofins Scientific SE - Segment focus
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: Hamilton Bonaduz AG - Overview
Exhibits143: Hamilton Bonaduz AG - Product / Service
Exhibits144: Hamilton Bonaduz AG - Key offerings
Exhibits145: Illumina Inc. - Overview
Exhibits146: Illumina Inc. - Business segments
Exhibits147: Illumina Inc. - Key news
Exhibits148: Illumina Inc. - Key offerings
Exhibits149: Illumina Inc. - Segment focus
Exhibits150: Pacific Biosciences of California Inc. - Overview
Exhibits151: Pacific Biosciences of California Inc. - Product / Service
Exhibits152: Pacific Biosciences of California Inc. - Key offerings
Exhibits153: PerkinElmer Inc. - Overview
Exhibits154: PerkinElmer Inc. - Business segments
Exhibits155: PerkinElmer Inc. - Key news
Exhibits156: PerkinElmer Inc. - Key offerings
Exhibits157: PerkinElmer Inc. - Segment focus
Exhibits158: Psomagen Inc. - Overview
Exhibits159: Psomagen Inc. - Product / Service
Exhibits160: Psomagen Inc. - Key offerings
Exhibits161: QIAGEN NV - Overview
Exhibits162: QIAGEN NV - Product / Service
Exhibits163: QIAGEN NV - Key news
Exhibits164: QIAGEN NV - Key offerings
Exhibits165: Takara Bio Inc. - Overview
Exhibits166: Takara Bio Inc. - Product / Service
Exhibits167: Takara Bio Inc. - Key offerings
Exhibits168: Tecan Trading AG - Overview
Exhibits169: Tecan Trading AG - Business segments
Exhibits170: Tecan Trading AG - Key offerings
Exhibits171: Tecan Trading AG - Segment focus
Exhibits172: Thermo Fisher Scientific Inc. - Overview
Exhibits173: Thermo Fisher Scientific Inc. - Business segments
Exhibits174: Thermo Fisher Scientific Inc. - Key news
Exhibits175: Thermo Fisher Scientific Inc. - Key offerings
Exhibits176: Thermo Fisher Scientific Inc. - Segment focus
Exhibits177: Zymo Research Corp. - Overview
Exhibits178: Zymo Research Corp. - Product / Service
Exhibits179: Zymo Research Corp. - Key offerings
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations

 

ページTOPに戻る


 

Summary

Global NGS-based RNA-seq Market 2023-2027
Technavio has been monitoring the NGS-based RNA-seq market and it is poised to grow by $3,753.73 mn during 2023-2027, accelerating at a CAGR of 15.34% during the forecast period. Our report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of next-generation sequencing methods, technological advancement in sequencing platforms, and the availability of wide range of next generation sequencing products.
Technavio's NGS-based RNA-seq market is segmented as below:
By End-user
• Academic and research centers
• Clinical research
• Pharma companies
• Hospitals
By Technology
• Sequencing by synthesis
• Ion semiconductor sequencing
• Single-molecule real-time sequencing
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the NGS-based RNA-seq market covers the following areas:
• NGS-based RNA-seq market sizing
• NGS-based RNA-seq market forecast
• NGS-based RNA-seq market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Brooks Automation Inc., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Precigen Inc., Pacific Biosciences of California Inc., PerkinElmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/ngs-based-rna-seq-market-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global NGS-based RNA-seq market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
o 4.2 End User Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
o 4.3 Technology Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Acamedic and research centers - Market size and forecast 2022-2027
o Exhibit 34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
o 6.4 Clinical research - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
o 6.5 Pharma companies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
o 6.6 Hospitals - Market size and forecast 2022-2027
o Exhibit 46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by End-user
o Exhibit 50: Market opportunity by End-user ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 51: Chart on Technology - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Technology - Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 53: Chart on Comparison by Technology
o Exhibit 54: Data Table on Comparison by Technology
o 7.3 Sequencing by synthesis - Market size and forecast 2022-2027
o Exhibit 55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
o 7.4 Ion semiconductor sequencing - Market size and forecast 2022-2027
o Exhibit 59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
o 7.5 Single-molecule real-time sequencing - Market size and forecast 2022-2027
o Exhibit 63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Technology
o Exhibit 71: Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Singapore - Market size and forecast 2022-2027
o Exhibit 105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 120: Agilent Technologies Inc. - Overview
o Exhibit 121: Agilent Technologies Inc. - Business segments
o Exhibit 122: Agilent Technologies Inc. - Key news
o Exhibit 123: Agilent Technologies Inc. - Key offerings
o Exhibit 124: Agilent Technologies Inc. - Segment focus
o 12.4 BGI Genomics Co. Ltd.
o Exhibit 125: BGI Genomics Co. Ltd. - Overview
o Exhibit 126: BGI Genomics Co. Ltd. - Product / Service
o Exhibit 127: BGI Genomics Co. Ltd. - Key offerings
o 12.5 Brooks Automation Inc.
o Exhibit 128: Brooks Automation Inc. - Overview
o Exhibit 129: Brooks Automation Inc. - Business segments
o Exhibit 130: Brooks Automation Inc. - Key offerings
o Exhibit 131: Brooks Automation Inc. - Segment focus
o 12.6 Eurofins Scientific SE
o Exhibit 132: Eurofins Scientific SE - Overview
o Exhibit 133: Eurofins Scientific SE - Business segments
o Exhibit 134: Eurofins Scientific SE - Key news
o Exhibit 135: Eurofins Scientific SE - Key offerings
o Exhibit 136: Eurofins Scientific SE - Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 Hamilton Bonaduz AG
o Exhibit 142: Hamilton Bonaduz AG - Overview
o Exhibit 143: Hamilton Bonaduz AG - Product / Service
o Exhibit 144: Hamilton Bonaduz AG - Key offerings
o 12.9 Illumina Inc.
o Exhibit 145: Illumina Inc. - Overview
o Exhibit 146: Illumina Inc. - Business segments
o Exhibit 147: Illumina Inc. - Key news
o Exhibit 148: Illumina Inc. - Key offerings
o Exhibit 149: Illumina Inc. - Segment focus
o 12.10 Pacific Biosciences of California Inc.
o Exhibit 150: Pacific Biosciences of California Inc. - Overview
o Exhibit 151: Pacific Biosciences of California Inc. - Product / Service
o Exhibit 152: Pacific Biosciences of California Inc. - Key offerings
o 12.11 PerkinElmer Inc.
o Exhibit 153: PerkinElmer Inc. - Overview
o Exhibit 154: PerkinElmer Inc. - Business segments
o Exhibit 155: PerkinElmer Inc. - Key news
o Exhibit 156: PerkinElmer Inc. - Key offerings
o Exhibit 157: PerkinElmer Inc. - Segment focus
o 12.12 Psomagen Inc.
o Exhibit 158: Psomagen Inc. - Overview
o Exhibit 159: Psomagen Inc. - Product / Service
o Exhibit 160: Psomagen Inc. - Key offerings
o 12.13 QIAGEN NV
o Exhibit 161: QIAGEN NV - Overview
o Exhibit 162: QIAGEN NV - Product / Service
o Exhibit 163: QIAGEN NV - Key news
o Exhibit 164: QIAGEN NV - Key offerings
o 12.14 Takara Bio Inc.
o Exhibit 165: Takara Bio Inc. - Overview
o Exhibit 166: Takara Bio Inc. - Product / Service
o Exhibit 167: Takara Bio Inc. - Key offerings
o 12.15 Tecan Trading AG
o Exhibit 168: Tecan Trading AG - Overview
o Exhibit 169: Tecan Trading AG - Business segments
o Exhibit 170: Tecan Trading AG - Key offerings
o Exhibit 171: Tecan Trading AG - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 172: Thermo Fisher Scientific Inc. - Overview
o Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 174: Thermo Fisher Scientific Inc. - Key news
o Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Zymo Research Corp.
o Exhibit 177: Zymo Research Corp. - Overview
o Exhibit 178: Zymo Research Corp. - Product / Service
o Exhibit 179: Zymo Research Corp. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 180: Inclusions checklist
o Exhibit 181: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 182: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 183: Research methodology
o Exhibit 184: Validation techniques employed for market sizing
o Exhibit 185: Information sources
o 13.5 List of abbreviations
o Exhibit 186: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global NGS-based RNA-seq market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Acamedic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Acamedic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pharma companies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pharma companies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pharma companies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pharma companies - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by End-user ($ million)
Exhibits51: Chart on Technology - Market share 2022-2027 (%)
Exhibits52: Data Table on Technology - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Technology
Exhibits54: Data Table on Comparison by Technology
Exhibits55: Chart on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Sequencing by synthesis - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Sequencing by synthesis - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Ion semiconductor sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Ion semiconductor sequencing - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Single-molecule real-time sequencing - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Technology ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Singapore - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Singapore - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Singapore - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Singapore - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Agilent Technologies Inc. - Overview
Exhibits121: Agilent Technologies Inc. - Business segments
Exhibits122: Agilent Technologies Inc. - Key news
Exhibits123: Agilent Technologies Inc. - Key offerings
Exhibits124: Agilent Technologies Inc. - Segment focus
Exhibits125: BGI Genomics Co. Ltd. - Overview
Exhibits126: BGI Genomics Co. Ltd. - Product / Service
Exhibits127: BGI Genomics Co. Ltd. - Key offerings
Exhibits128: Brooks Automation Inc. - Overview
Exhibits129: Brooks Automation Inc. - Business segments
Exhibits130: Brooks Automation Inc. - Key offerings
Exhibits131: Brooks Automation Inc. - Segment focus
Exhibits132: Eurofins Scientific SE - Overview
Exhibits133: Eurofins Scientific SE - Business segments
Exhibits134: Eurofins Scientific SE - Key news
Exhibits135: Eurofins Scientific SE - Key offerings
Exhibits136: Eurofins Scientific SE - Segment focus
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: Hamilton Bonaduz AG - Overview
Exhibits143: Hamilton Bonaduz AG - Product / Service
Exhibits144: Hamilton Bonaduz AG - Key offerings
Exhibits145: Illumina Inc. - Overview
Exhibits146: Illumina Inc. - Business segments
Exhibits147: Illumina Inc. - Key news
Exhibits148: Illumina Inc. - Key offerings
Exhibits149: Illumina Inc. - Segment focus
Exhibits150: Pacific Biosciences of California Inc. - Overview
Exhibits151: Pacific Biosciences of California Inc. - Product / Service
Exhibits152: Pacific Biosciences of California Inc. - Key offerings
Exhibits153: PerkinElmer Inc. - Overview
Exhibits154: PerkinElmer Inc. - Business segments
Exhibits155: PerkinElmer Inc. - Key news
Exhibits156: PerkinElmer Inc. - Key offerings
Exhibits157: PerkinElmer Inc. - Segment focus
Exhibits158: Psomagen Inc. - Overview
Exhibits159: Psomagen Inc. - Product / Service
Exhibits160: Psomagen Inc. - Key offerings
Exhibits161: QIAGEN NV - Overview
Exhibits162: QIAGEN NV - Product / Service
Exhibits163: QIAGEN NV - Key news
Exhibits164: QIAGEN NV - Key offerings
Exhibits165: Takara Bio Inc. - Overview
Exhibits166: Takara Bio Inc. - Product / Service
Exhibits167: Takara Bio Inc. - Key offerings
Exhibits168: Tecan Trading AG - Overview
Exhibits169: Tecan Trading AG - Business segments
Exhibits170: Tecan Trading AG - Key offerings
Exhibits171: Tecan Trading AG - Segment focus
Exhibits172: Thermo Fisher Scientific Inc. - Overview
Exhibits173: Thermo Fisher Scientific Inc. - Business segments
Exhibits174: Thermo Fisher Scientific Inc. - Key news
Exhibits175: Thermo Fisher Scientific Inc. - Key offerings
Exhibits176: Thermo Fisher Scientific Inc. - Segment focus
Exhibits177: Zymo Research Corp. - Overview
Exhibits178: Zymo Research Corp. - Product / Service
Exhibits179: Zymo Research Corp. - Key offerings
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/06 10:26

151.06 円

160.23 円

195.43 円

ページTOPに戻る